-
IntroducedJan 08, 2021
-
Passed HouseJan 27, 2021
-
Passed SenateMar 23, 2021
-
Signed into LawApr 01, 2021
Relating to duration limits for opioid therapy and benzodiazepine; and to provide for application.
Last Action See all actions
executive • Apr 05, 2021: Filed with Secretary Of State 04/01
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HB 1139
Tweets
Whip Lists
Sponsors
Votes
YES: 64
- Anderson, B.
- Anderson, D.
- Beltz
- Bosch
- Boschee
- Brandenburg
- Cory
- Damschen
- Delzer
- Devlin
- Dockter
- Fisher
- Hager
- Hagert
- Hatlestad
- Headland
- Heinert
- Howe
- Ista
- Johnson, D.
- Jones
- Karls
- Keiser
- Kempenich
- Kiefert
- Klemin
- Kreidt
- Lefor
- Longmuir
- Louser
- Martinson
- Meier
- Mitskog
- Mock
- Monson
- Nathe
- Nelson, J.
- O'Brien
- Ostlie
- Owens
- Pollert
- Pyle
- Richter
- Roers Jones
- Ruby, D.
- Ruby, M.
- Sanford
- Satrom
- Schatz
- Schauer
- Schmidt
- Schreiber-Beck
- Steiner
- Stemen
- Strinden
- Thomas
- Trottier
- Tveit
- Vetter
- Vigesaa
- Weisz
- Westlind
- Zubke
- Speaker Koppelman, K.
NO: 26
ABSENT: 4
Actions
- Apr 05, 2021 | executive
- Filed with Secretary Of State 04/01
- Apr 01, 2021 | House
- Signed by Governor 03/31
- Mar 29, 2021 | House
- Signed by Speaker
- Sent to Governor
- Mar 25, 2021 | Senate
- Signed by President
- Mar 24, 2021 | House
- Returned to House
- Mar 23, 2021 | Senate
- Second reading, passed, yeas 38 nays 8
- Mar 22, 2021 | Senate
- Reported back, do pass, place on calendar 5 1 0
- Mar 08, 2021 | Senate
- Bill Hearing, Senate Industry, Business and Labor, 03/08 2:30 PM, Room Fort Union - relating to duration limits for opioid therapy and benzodiazepine
- Committee Hearing 02:30
- Feb 15, 2021 | Senate
- Introduced, first reading, referred Industry, Business and Labor Committee
- Jan 28, 2021 | Senate
- Received from House
- Jan 27, 2021 | House
- Second reading, passed, yeas 64 nays 26
- Jan 21, 2021 | House
- Reported back, do pass, place on calendar 12 1 1
- Jan 18, 2021 | House
- Bill Hearing, House Industry, Business and Labor, 01/18 8:00 AM, Room 327C - Duration limits for opioid therapy & benzodiazepine.
- Committee Hearing 08:00
- Jan 08, 2021 | House
- Introduced, first reading, referred Industry, Business and Labor Committee
Bill Texts
Documents
- Legislative HistoryPDF
- Fiscal Note (INTRODUCED)PDF
- Video - Industry, Business and Labor, 01/18 08:00 AM (HB 1139 - Duration limits for opioid therapy & benzodiazepine.)
- Video - Industry, Business and Labor, 01/20 02:00 PM (Committee Work - Committee work on HB 1139, HB 1204 & HB 1086.)
- Video - House, 01/27 01:24 PM (11th Order - Final Passage House Measures - HB1139 - Industry, Business and Labor - Do Pass)
- Video - House, 01/27 01:25 PM (Representative Keiser)
- Video - House, 01/27 01:26 PM (Representative Becker)
- Video - House, 01/27 01:28 PM (Representative M. Nelson)
- Video - House, 01/27 01:31 PM (Representative Lefor)
- Video - House, 01/27 01:33 PM (Representative Hoverson)
- Video - House, 01/27 01:34 PM (11th Order - Final Passage House Measures - HB1139 - Industry, Business and Labor - Do Pass - Votes Required 48: PASSED - Yea 64 Nay 26 N/V 4 Exc 0)
- Video - Industry, Business and Labor, 03/08 02:30 PM (HB 1139 - relating to duration limits for opioid therapy and benzodiazepine)
- Video - Industry, Business and Labor, 03/22 02:55 PM (HB 1139 opiod use)
- Video - Industry, Business and Labor, 03/22 02:56 PM (HB 1139 relating to duration limits for opioid therapy and benzodiazepine)
- Video - Industry, Business and Labor, 03/22 02:57 PM (Roll call vote on a Do pass on HB 1139 5-1-0)
- Video - Senate, 03/23 02:19 PM (14th Order - Final Passage House Measures - HB1139 - Industry, Business and Labor - Do Pass)
- Video - Senate, 03/23 02:20 PM (Senator Klein)
- Video - Senate, 03/23 02:23 PM (Senator Piepkorn)
- Video - Senate, 03/23 02:24 PM (Senator Klein)
- Video - Senate, 03/23 02:25 PM (14th Order - Final Passage House Measures - HB1139 - Industry, Business and Labor - Do Pass - Votes Required 24: PASSED - Yea 38 Nay 8 N/V 1 Exc 0)
- Video - Senate, 03/23 04:11 PM (14th Order - Final Passage House Measures - HB1139 - Industry, Business and Labor - Do Pass)
- Video - Senate, 03/23 04:11 PM (14th Order - Final Passage House Measures - HB1139 - Industry, Business and Labor - Do Pass)
- Video - Senate, 03/23 04:27 PM (14th Order - Final Passage House Measures - HB1139 - Industry, Business and Labor - Do Pass)
- Testimony (In Favor) -- George Keiser, District 67, Bismarck, ND (Senate Industry, Business and Labor, 03/08 02:35 PM)PDF
- Testimony (In Opposition) -- Beth A. Larson-Steckler, Patient Advocate, Bismarck, ND (Senate Industry, Business and Labor, 03/07 08:02 PM)PDF
- Testimony (In Opposition) -- Mike Booth, AMA alternate delegate, Bismarck, ND (Senate Industry, Business and Labor, 03/06 03:32 PM)PDF
- Testimony (In Opposition) -- Mike Booth, AMA alternate delegate, Bismarck, ND (Senate Industry, Business and Labor, 03/06 03:32 PM)PDF
- Testimony (In Favor) -- Tim Wahlin, Chief of Injury Services, Bismarck, ND (Senate Industry, Business and Labor, 03/05 01:10 PM)PDF
- Testimony (In Favor) -- Paula M. Moch, Legislative Liaison, Braddock, ND (Senate Industry, Business and Labor, 03/06 07:46 AM)PDF
- Testimony (In Favor) -- North Dakota Medical Association, (House Industry, Business and Labor, 01/20 02:06 PM)PDF
- Testimony (Neutral) -- Jodi Bjornson, General Counsel, Bismarck, ND (House Industry, Business and Labor, 01/18 02:06 PM)PDF
- Testimony (In Opposition) -- Michael Booth, MD, Bismarck, ND (House Industry, Business and Labor, 01/18 08:34 AM)PDF
- Testimony (In Favor) -- Harvey Hanel, Medical Services & Pharmacy Director, Bismarck, ND (House Industry, Business and Labor, 01/15 02:17 PM)PDF
- Testimony (In Favor) -- Tim Wahlin, Chief of Injury Services, Bismarck, ND (House Industry, Business and Labor, 01/15 02:10 PM)PDF